Monday, June 17, 2024
HomeTagsSentynl Therapeutics

Sentynl Therapeutics

Sentynl Therapeutics Announces Global Acquisition of Zokinvy® (Lonafarnib) for Treatment of Hutchinson-Gilford Progeria Syndrome from Eiger BioPharmaceuticals

Sentynl Therapeutics, Inc., a U.S.-based biopharmaceutical company wholly-owned by Zydus Lifesciences, Ltd. (Zydus Group), and Eiger BioPharmaceuticals, Inc., a commercial-stage biopharmaceutical company focused on the development of...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics